Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms

Authors

  • Ugur Kuyumcuoglu Dr. Lütfi Kirdar Training and Research Hospital 1. Urology Clinic, Istanbul, Turkey
  • Bilal Eryildirim Dr. Lütfi Kirdar Training and Research Hospital 1. Urology Clinic, Istanbul, Turkey
  • Murat Tuncer Dr. Lütfi Kirdar Training and Research Hospital 1. Urology Clinic, Istanbul, Turkey
  • Gokhan Faydaci Dr. Lütfi Kirdar Training and Research Hospital 1. Urology Clinic, Istanbul, Turkey
  • Fatih Tarhan Dr. Lütfi Kirdar Training and Research Hospital 1. Urology Clinic, Istanbul, Turkey
  • Aydin Ozgül Dr. Lütfi Kirdar Training and Research Hospital 1. Urology Clinic, Istanbul, Turkey

DOI:

https://doi.org/10.5489/cuaj.145

Abstract

Background: We investigated whether the frequency of lower urinary tract symptoms (LUTS) increased in patients in whom double-J stents were applied. We also evaluated several medical therapy protocols to treat symptoms related with ureteral stents.

Materials and Methods: A total of 108 patients, in whom unilateral double-j stent was applied during ureteral stone treatment, were included. Before the double-J stent was applied, all patients completed storage components of the “International Prostate Symptom Score” (IPSSs), quality of life components of the IPSS (IPSS-QOL) and “Overactive Bladder Questionnaire” (OABq) forms and scores were calculated. After the procedure, cases were randomized into 5 groups, an antiinflammatory was given to Group 1, spasmolytic to Group 2, anticholinergic to Group 3 and α-blocker to Group 4. No additional drug was given to Group 5 as this control group. During the fourth week of the procedure, IPSSs, IPSS-QOL and OABq forms were again completed and scores were compared with the previous ones.

Results: When all the cases were evaluated, the IPSSs, IPSS-QOLand OABq scores of patients in whom the double-J stent was applied were statistically significantly higher the procedure. Compared to the control group, the cases where the double-J stent was applied showed a higher IPSSs, IPSS-QOL and OABq scores and none of the medical therapies could prevent this increase.

Interpretation: The frequency of LUTS increased in cases where the ureteral stent was applied and discomfort continued as long as the stent stayed in the body.

Downloads

Download data is not yet available.

Downloads

Published

2012-12-13

How to Cite

Kuyumcuoglu, U., Eryildirim, B., Tuncer, M., Faydaci, G., Tarhan, F., & Ozgül, A. (2012). Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Canadian Urological Association Journal, 6(6), e234–7. https://doi.org/10.5489/cuaj.145

Issue

Vol. 6 No. 6 (2012): CUAJ December

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.